James M. Perel

13.1k total citations · 1 hit paper
175 papers, 9.5k citations indexed

About

James M. Perel is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, James M. Perel has authored 175 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Psychiatry and Mental health, 44 papers in Pharmacology and 37 papers in Clinical Psychology. Recurrent topics in James M. Perel's work include Treatment of Major Depression (35 papers), Maternal Mental Health During Pregnancy and Postpartum (27 papers) and Child and Adolescent Psychosocial and Emotional Development (24 papers). James M. Perel is often cited by papers focused on Treatment of Major Depression (35 papers), Maternal Mental Health During Pregnancy and Postpartum (27 papers) and Child and Adolescent Psychosocial and Emotional Development (24 papers). James M. Perel collaborates with scholars based in United States, Armenia and United Kingdom. James M. Perel's co-authors include Neal D. Ryan, Katherine L. Wisner, Ronald E. Dahl, Boris Birmaher, Douglas E. Williamson, Joan Kaufman, David A. Brent, Beverly Nelson, Peter G. Dayton and Barbara H. Hanusa and has published in prestigious journals such as Nature, New England Journal of Medicine and JAMA.

In The Last Decade

James M. Perel

172 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Childhood and Adolescent Depression: A Review of the Past 10 Years. Part I

1996 1.6k citations Boris Birmaher, Neal D. Ryan et al. Journal of the American Academy of Child & Adolescent Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James M. Perel United States	48	3.9k	2.7k	2.4k	1.6k	1.3k	175	9.5k
Gabor I. Keitner United States	47	4.3k 1.1×	2.8k 1.1×	1.2k 0.5×	1.8k 1.1×	1.9k 1.5×	121	9.0k
Peter R. Joyce New Zealand	59	7.3k 1.9×	3.3k 1.2×	1.2k 0.5×	1.2k 0.8×	1.7k 1.3×	306	11.8k
Dušan Hadži-Pavlović Australia	57	4.3k 1.1×	3.9k 1.4×	1.5k 0.6×	1.7k 1.1×	1.8k 1.4×	266	10.9k
Tulshi D. Saha United States	46	5.4k 1.4×	1.8k 0.7×	1.4k 0.6×	2.3k 1.4×	1.9k 1.5×	71	13.9k
Doreen Koretz United States	13	3.5k 0.9×	1.7k 0.6×	1.0k 0.4×	1.4k 0.9×	2.1k 1.6×	18	8.7k
Boji Huang United States	35	4.7k 1.2×	1.7k 0.6×	1.2k 0.5×	1.7k 1.1×	1.4k 1.1×	51	11.2k
Roger P. Pickering United States	42	6.5k 1.7×	2.3k 0.8×	1.3k 0.6×	2.5k 1.6×	2.1k 1.6×	57	15.6k
Alan J. Gelenberg United States	49	1.8k 0.5×	3.5k 1.3×	895 0.4×	2.7k 1.7×	1.1k 0.9×	158	8.7k
Arthur I. Alterman United States	59	3.9k 1.0×	1.9k 0.7×	1.7k 0.7×	617 0.4×	1.4k 1.1×	254	10.6k
Roger D. Weiss United States	72	5.2k 1.4×	3.8k 1.4×	3.9k 1.7×	2.1k 1.3×	2.0k 1.6×	351	17.3k

Countries citing papers authored by James M. Perel

Since Specialization

Citations

This map shows the geographic impact of James M. Perel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Perel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Perel more than expected).

Fields of papers citing papers by James M. Perel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Perel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Perel. The network helps show where James M. Perel may publish in the future.

Co-authorship network of co-authors of James M. Perel

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Perel. A scholar is included among the top collaborators of James M. Perel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Perel. James M. Perel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Porta, Giovanna, Tina R. Goldstein, Dara Sakolsky, et al.. (2011). Pharmacokinetically and Clinician-Determined Adherence to an Antidepressant Regimen and Clinical Outcome in the TORDIA Trial. Journal of the American Academy of Child & Adolescent Psychiatry. 50(5). 490–498. 40 indexed citations

Bogen, Debra L., James M. Perel, Joseph C. Helsel, et al.. (2011). Estimated Infant Exposure to Enantiomer-Specific Methadone Levels in Breastmilk. Breastfeeding Medicine. 6(6). 377–384. 22 indexed citations

Sakolsky, Dara, James M. Perel, Graham J. Emslie, et al.. (2010). Antidepressant Exposure as a Predictor of Clinical Outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) Study. Journal of Clinical Psychopharmacology. 31(1). 92–97. 43 indexed citations

Daviss, W. Burleson, et al.. (2006). Steady-State Clinical Pharmacokinetics of Bupropion Extended-Release in Youths. Journal of the American Academy of Child & Adolescent Psychiatry. 45(12). 1503–1509. 13 indexed citations

Cohen, Judith A. & James M. Perel. (2004). Adolescent Weight Loss During Treatment with Olanzapine. Journal of Child and Adolescent Psychopharmacology. 14(4). 617–620. 6 indexed citations

Wisner, Katherine L., James M. Perel, Kathleen Peindl, et al.. (2001). Prevention of Recurrent Postpartum Depression. The Journal of Clinical Psychiatry. 62(2). 82–86. 140 indexed citations

Mavissakalian, Matig & James M. Perel. (2001). 2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia.. Annals of Clinical Psychiatry. 13(2). 63–67. 13 indexed citations

Frank, Guido, Walter H. Kaye, Theodore E. Weltzin, et al.. (2001). Altered response to meta‐chlorophenylpiperazine in anorexia nervosa: Support for a persistent alteration of serotonin activity after short‐term weight restoration. International Journal of Eating Disorders. 30(1). 57–68. 30 indexed citations

Cornelius, Jack R., Ihsan M. Salloum, Roger F. Haskett, et al.. (2000). Fluoxetine versus placebo in depressed alcoholics. Addictive Behaviors. 25(2). 307–310. 39 indexed citations

10.

Cornelius, Jack R., et al.. (1999). Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Addictive Behaviors. 24(1). 111–114. 40 indexed citations

11.

Wisner, Katherine L. & James M. Perel. (1998). Serum Levels of Valproate and Carbamazepine in Breastfeeding Mother-Infant Pairs. Journal of Clinical Psychopharmacology. 18(2). 167–169. 43 indexed citations

12.

Wisner, Katherine L., James M. Perel, & Jeffrey L. Blumer. (1998). Serum Sertraline and N-Desmethylsertraline Levels in Breast-Feeding Mother-Infant Pairs. American Journal of Psychiatry. 155(5). 690–692. 59 indexed citations

13.

Reynolds, Charles F., Mary Amanda Dew, Ellen Frank, et al.. (1998). Effects of Age at Onset of First Lifetime Episode of Recurrent Major Depression on Treatment Response and Illness Course in Elderly Patients. American Journal of Psychiatry. 155(6). 795–799. 81 indexed citations

14.

Mammen, Oommen, et al.. (1997). Sertraline and Norsertraline Levels in Three Breastfed Infants. The Journal of Clinical Psychiatry. 58(3). 100–103. 50 indexed citations

15.

Kahn, Eugen, et al.. (1990). Change in Haloperidol Level Due to Carbamazepine???A Complicating Factor in Combined Medication for Schizophrenia. Journal of Clinical Psychopharmacology. 10(1). 54–57. 36 indexed citations

16.

Kupfer, David J., Cindy L. Ehlers, Bruce G. Pollock, Rajan Nathan, & James M. Perel. (1989). Clomipramine and EEG sleep in depression. Psychiatry Research. 30(2). 165–180. 55 indexed citations

17.

Zubenko, George S., et al.. (1988). Platelet membrane fluidity and treatment response in cognitively-impaired, depressed elderly: initial results. Psychopharmacology. 94(3). 347–349. 5 indexed citations

18.

Dayton, Peter G., James M. Perel, Robert F. Cunningham, Zafar H. Israili, & I. M. Weiner. (1973). STUDIES OF THE FATE OF METABOLITES AND ANALOGS OF PROBENECID. Drug Metabolism and Disposition. 1(6). 742–751. 10 indexed citations

19.

Dayton, Peter G., et al.. (1966). Ascorbic and Dehydroascorbic Acids in Guinea Pigs and Rats. Journal of Nutrition. 88(3). 338–344. 16 indexed citations

20.

Burns, J.J., et al.. (1957). A POTENT NEW URICOSURIC AGENT, THE SULFOXIDE METABOLITE OF THE PHENYLBUTAZONE ANALOGUE, G-25671. Journal of Pharmacology and Experimental Therapeutics. 119(3). 418–426. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact